Ned Sharpless, MDOvjeren akaunt

@NCIDirector

Official Twitter account of Norman E. “Ned” Sharpless, MD, Director of . Follows & retweets are not endorsements. Privacy: .

Bethesda, MD
Vrijeme pridruživanja: srpanj 2017.

Tweetovi

Blokirali ste korisnika/cu @NCIDirector

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NCIDirector

  1. Another successful Town Hall! I say this frequently, but I can’t stress it enough: I feel like I have the best job in the federal government. I’m grateful to lead such a dedicated and talented group.

    Poništi
  2. Congrats to Drs. Steeg, Thiele, and Shah for their tenure as Women Scientist Advisors. Proud of the work they do for , especially their commitment to mentorship. is a key part of our focus on supporting the .

    Poništi
  3. proslijedio/la je Tweet
    31. sij

    The steep bump in incidence of between 49 & 50 years suggesting an undiagnosed cohort of established cancer that exists in the >50Y pre-colonoscopy period. Note that recommends colonoscopy begin at 45y.

    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet

    Newly Activated Trial: (S1900C) Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation, a Sub-Study of , led by Learn more:

    Poništi
  5. We encourage more women-owned small businesses to apply for ’s funding. Our team is always here to help .

    Prikaži ovu nit
    Poništi
  6. While there is still more work to be done, these efforts are starting to pay off, leading to a sizable increase in the number of new awards to women.

    Prikaži ovu nit
    Poništi
  7. The Applicant Assistance Program offers application coaching to people who have never received SBIR/STTR funding from the , including women-owned small businesses.

    Prikaži ovu nit
    Poništi
  8. We take this issue seriously at . Last year, we convened a working group to provide strategic recommendations, which led to the development of the Applicant Assistance Program.

    Prikaži ovu nit
    Poništi
  9. Diversity fosters innovation. By supporting small businesses founded by women, we can enable new technologies that help cancer patients.

    Prikaži ovu nit
    Poništi
  10. As this story by shows, women face challenges in biotech. NCI can help address this through ’s programs for small businesses.

    Prikaži ovu nit
    Poništi
  11. I say this often, but it’s worth repeating: it really is a special time for cancer research and cancer progress. We’re seeing more and more evidence of that progress, including today’s report from as reported by of

    Poništi
  12. proslijedio/la je Tweet

    New report shows life expectancy in the U.S. ⬆️ in 2018 for the first time in four years! We're now on the right trajectory to longevity for all Americans. Read the report to learn more:

    Poništi
  13. FDA v CA Stem Cell clinics is headed to court. Outside of the context of a clinical trial, patients with cancer should avoid risky, unproven therapies. Column: U.S. judge rejects FDA bid to shut down stem cell clinics, dealing blow to regulators

    Poništi
  14. proslijedio/la je Tweet
    28. sij

    African Americans suffer from lung cancer more than any other population in the U.S., according to We applaud our partners at for partnering with and for addressing this critical group. Cancer trials are for everyone.

    Poništi
  15. With this testing, patients and their care teams will have more opportunities to personalize cancer care and potentially improve outcomes.

    Prikaži ovu nit
    Poništi
  16. Pleased with ’s decision to expand coverage of genetic testing for hereditary breast and ovarian cancer. This is an important step forward in supporting women’s health.

    Prikaži ovu nit
    Poništi
  17. proslijedio/la je Tweet

    It's never too late to quit smoking. Learn more about my new report with the latest data & science on the health benefits of smoking cessation:

    Poništi
  18. proslijedio/la je Tweet
    24. sij

    Are you new to NCI ? Sign up for email updates to get the latest news on funding opportunities and program resources geared toward supporting your commercialization journey:

    Poništi
  19. proslijedio/la je Tweet
    16. sij

    Join and keynote speaker for 's birthday recognition and public meeting on Feb. 5 at FDA or online to discuss the future of oncology drug development

    Prikaži ovu nit
    Poništi
  20. proslijedio/la je Tweet
    23. sij

    data release 22 is now available! Includes new Clinical Proteomic Tumor Analysis Consortium () project data from the Glioblastoma Multiforme Discovery Study and CPTAC-3 miRNA sequencing data. Find out more:

    New CPTAC Data Release on GDC
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·